(October 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has acquired a portfolio of proprietary endoscopic stent technologies from Willy Rüsch GmbH (Rüsch), a Teleflex Medical company. The technologies are used to treat gastrointestinal (GI) and airway obstructions. This portfolio includes assets related to the Polyflex